Compounding Pharmacies

HHS Weighs Letting Pharmacies Compound Unapproved Peptides; FDA Staff Cite Thin Data

HHS and FDA sent an interim access policy to the White House budget office, per a trade publication. Supporters say regulated pharmacies are safer than gray markets; critics cite limited evidence.